Hiv Prevention in Treatment Settings: U.S. and International Priorities
The summary for the Hiv Prevention in Treatment Settings: U.S. and International Priorities grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Hiv Prevention in Treatment Settings: U.S. and International Priorities: The estimated annual number of new HIV infections in the U.S. has remained steady at 40,000 for nearly ten years and HIV rates in many countries continue to rise alarmingly. Domestic and international HIV prevention programs have generally focused on HIV-negative persons, to help them avoid becoming infected. However, it has become increasingly apparent that to stem the tide of new infections, additional attention and resources should be focused on persons living with HIV, especially those in treatment. Behavioral interventions in HIV/AIDS treatment settings represent a critical domestic priority and are an emergent international priority. To develop enhanced HIV prevention strategies in treatment settings, there are important research gaps in basic, behavioral science, medical, and policy areas that need to be addressed. Studies are needed to (a) better understand the associations among HIV treatment response, treatment adherence, risk behavior, and other psychosocial factors that are likely to impact these variables (e.g., housing instability, substance abuse, depression, domestic violence); (b) develop innovative approaches to risk behavior change based in treatment settings, especially interventions that combine behavioral and medical/biological components; (c) examine optimal mechanisms for referral to services for prevention needs that are not feasible in medical settings; (d) increase medical care providers' linkage of persons to care who had previously not known their HIV serostatus; and (e) improve utilization of systems to facilitate partner notification. This Request for Applications (RFA) briefly reviews the complex interaction of basic, behavioral science, medical, and public policy issues that present challenges for the integration of HIV prevention into clinical care settings, and outlines important research priorities.
|Federal Grant Title:||Hiv Prevention in Treatment Settings: U.S. and International Priorities|
|Federal Agency Name:||National Institutes of Health|
|Grant Categories:||Health Education|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-MH-03-006|
|Type of Funding:||Grant|
|CFDA Descriptions:||Mental Health Research Grants 93.279 Drug Abuse Research Programs|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Oct 29, 2002|
|Posted Date:||Jul 26, 2002|
|Creation Date:||Dec 09, 2002|
|Archive Date:||Dec 09, 2002|
|Total Program Funding:|
|Maximum Federal Grant Award:|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||93.361 -- Nursing Research|
- Applicants Eligible for this Grant
- State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Individuals For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster OERWebmaster@od.nih.gov NIH OER Webmaster
- More Grants from the National Institutes of Health
- • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
- • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
- • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
- • HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
- • National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...